10 March 2020 - Today, we are providing an update on the status of U.S. FDA inspections outside of the U.S. in response to the COVID-19 outbreak. 

After careful consideration, the FDA is postponing most foreign inspections through April, effective immediately. 

Inspections outside the U.S. deemed mission-critical will still be considered on a case-by-case basis.

Read FDA press release